Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Canadian Political Free-for-All -- Ignore unavailable to you. Want to Upgrade?

To: Gulo who wrote (3822)	4/3/2004 10:19:13 AM
From: Stephen O	Respond to of 37571

From the BBC, this is part of the whole story. Race chief wants integration push The race chief's call means a u-turn for the commission Trevor Phillips, head of the Commission for Racial Equality, has called for all citizens to "assert a core of Britishness". In an interview for the Times newspaper he said the term "multiculturalism" was of another era and should be scrapped. I like that last paragraph and just exchange Britishness to Canadian ????. Here's the full story URL news.bbc.co.uk

To: Gulo who wrote (3822)	4/29/2004 10:39:52 PM
From: NOW	Read Replies (2) \| Respond to of 37571

Please : why go on about something which you seem to know so little about? why not leave it to those in the know like the former editors of the NEw England Journal Of Medicine: " The drug companies maintain that this is the price of success. They portray their industry as a highly risky one in a competitive market -- just able to cover its enormous research and development costs but managing nonetheless to deliver a stream of innovative drugs in the public interest. Here are the facts. The pharmaceutical giants spend two or three times as much on marketing and administration as they do on R&D, and their profits are about twice their R&D costs. To cite a typical example, last year GlaxoSmithKline spent 37 percent of its revenues on marketing and administration and only 14 percent on R&D, while making a 28 percent profit. Overall, the pharmaceutical industry is by far the most profitable in the United States. " washingtonpost.com